Antigen receptor (immunoglobulin and T-cell receptor) gene rearrangements: Utility in Routine Diagnostic Hematopathology

Similar documents
Clonality testing Potentials & Problems

IgH/TCR Clonality Status. Performance Monitoring Cover Sheet. Final IgH Clonality Result IGH 131. Uncontrolled Copy

European guidelines for the universal description of Ig / TCR clonality testing data

Elevated Immunoglobulins and Paraproteins

Applications of the Ion AmpliSeq Immune Repertoire Assay Plus TCRβ

T and B cell gene rearrangement October 17, Ram Savan

IMMUNOGLOBULIN GENES UNDERGO TWO DNA REARRANGEMENTS

Leukemia (2003) 17, & 2003 Nature Publishing Group All rights reserved /03 $

Immunoglobulins: Structure and Function

bioinformatics: state of art tools for NGS immunogenetics

GENETIC BASIS OF ANTIBODY STRUCTURE AND DIVERSITY. Steven J. Norris, Ph.D

Immunoglobulin/T-cell receptor clonality diagnostics

Atlas of Genetics and Cytogenetics in Oncology and Haematology. IMMUNOGLOBULIN GENES: CONCEPT OF DNA REARRANGEMENT * Introduction

Flow Cytometry in the Diagnosis of Hematopoietic Neoplasia. Brent Wood MD, PhD Professor, Laboratory Medicine University of Washington, Seattle

Minimal Residual Disease assessment in Multiple Myeloma by Next-Generation Sequencing

LECTURE: 22 IMMUNOGLOBULIN DIVERSITIES LEARNING OBJECTIVES: The student should be able to:

IdentiClone TCRD Gene Clonality Assay For Identification of Clonal T Cell Receptor Delta Chain Gene Rearrangements For In Vitro Diagnostic Use

Roche Molecular Biochemicals Technical Note No. LC 10/2000

SPECIFICITY, DIVERSITY, AND IMMUNOGLOBULIN GENES

Rapid Cycle PCR, Real Time Analysis, and Hi-Res Melting

بسم هللا الرحمن الرحيم. Today we're going to talk about the generation of diversity of the receptors of the lymphocytes

IMGT Locus on Focus. ABC Fax Marie-Paule Lefranc

American Society of Cytopathology Core Curriculum in Molecular Biology

Implementation of Ion AmpliSeq in molecular diagnostics

Cancer Genetics Solutions

Genetics Lecture 21 Recombinant DNA

In vitro cultures of bone marrow stromal cells and progenitor B cells can accurately recapitulate the normal steps of B cell development.

B cell development The stages of B cell development

Schaller et al. BMC Bioinformatics (2015) 16:252 DOI /s

IdentiClone T Cell Receptor Gamma Gene

Tumor immunotherapy by an engineering T cell receptor: a proposed hypothesis and study design

Immunoglobulins Harry W Schroeder Jr MD PhD

Hot Topic. Disclosures. None

1001 NW Technology Drive, Lee's Summit, MO // (800) // (816) Fax //

Diagnosis and Follow-up of Multiple Myeloma and Related Disorders: The role of the laboratory

Advances in B Lymphblastic Leukemia MRD. Brent Wood MD PhD Departments of Laboratory Medicine and Pathology University of Washington.

The Polymerase Chain Reaction. Chapter 6: Background

Antibody Structure. Antibodies

Antibody Structure supports Function

3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) Fax: (905)

DNA Technology. Asilomar Singer, Zinder, Brenner, Berg

Epstein Barr Virus (Human Herpes virus 4)

Genome research in eukaryotes

Technical Advance. Frank C. Kuo, Dimity Hall, and Janina A. Longtine

MILESTONE. Optimized Molecular Results. BoneSTATION Advanced system for fixation and decalcification of bone tissues

Molecular methods in medical microbiology: Current and future trends

The Seed Health Toolbox II. Molecular Seed Testing Methods and Processes: What are the sources of variability?

GREAT STRIDES IN SCIENCE WHAT ABOUT ACCESS? Marlene E. Haffner, MD, MPH 2nd IRDiRC Conference Shenzhen, China November 8, 2014

THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA. themmrf.org

Troubleshooting of Real Time PCR Ameer Effat M. Elfarash

NOTES - CH 15 (and 14.3): DNA Technology ( Biotech )

PV92 PCR Bio Informatics

Oncomine cfdna Assays Part III: Variant Analysis

NRAS Mutation Analysis Reagents (Codons 12 and 13)

Detection of Clonal T-Cell Receptor-gamma Gene Rearrangement by PCR/Temporal Temperature Gradient Gel Electrophoresis

CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION

LATE-PCR. Linear-After-The-Exponential

First Annual Biomarker Symposium Quest Diagnostics Clinical Trials

Urine Protein Electrophoresis and Immunoelectrophoresis Using Unconcentrated or Minimally Concentrated Urine Samples

FORENSIC GENETICS. DNA in the cell FORENSIC GENETICS PERSONAL IDENTIFICATION KINSHIP ANALYSIS FORENSIC GENETICS. Sources of biological evidence

Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A

Sanger sequencing troubleshooting guide. GATC Biotech AG

4000: Cellular Therapy Essential Data Pre- Infusion

Lecture 3. Used anti B cell marker antibodies to deplete in mice

Mycobacterium tuberculosis End-Point PCR Kit Product# EP42100

LightScanner Hi-Res Melting Comparison of Six Master Mixes for Scanning and Small Amplicon and LunaProbes Genotyping

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma

TaKaRa MiniBEST Viral RNA/DNA Extraction Kit Ver.5.0

Genetics - Problem Drill 19: Dissection of Gene Function: Mutational Analysis of Model Organisms

TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT

American Society of Cytopathology Core Curriculum in Molecular Biology

Application Note. NGS Analysis of B-Cell Receptors & Antibodies by AptaAnalyzer -BCR

Systematic Analysis of single cells by PCR

Lecture 14 - PCR Applications and Lab Practicum (AMG text pp ) October 9, 2001

Multiple choice questions (numbers in brackets indicate the number of correct answers)

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma

AmoyDx JAK2 Mutation Detection Kit

In Situ Analysis of the Variable Heavy Chain Gene of an IgM/IgG-Expressing Follicular Lymphoma

Human Papillomavirus 52 and 52b

Chapter 15 Gene Technologies and Human Applications

DNA MUTATION ANALYSIS OF THE VH4 INTRON LOCUS IN SMURF2 KNOCKOUT MICE

Antibiotic resistance OXA -48 Carbapenem-hydrolyzing β- lactamase (blaoxa-48) gene. genesig Advanced Kit. 150 tests.

Epstein-Barr virus (EBV) Detection with real time PCR reagents

Taura Syndrome Virus (TSV) RT-PCR Kit

HELINI White spot Syndrome virus [WSSV] Real-time PCR Kit

Dengue Virus subtypes 1,2 3 and 4

AmoyDx JAK2 Mutation Detection Kit

Protein homology. Antigens & Antibodies I. Administrative issues:

LightCycler 480 qpcr Tools. Meeting the Challenge of Your Research

Amplicon Sequencing Template Preparation

AmoyDx TM JAK2 V617F Mutation Detection Kit

Do Donors With Non-Deletional Blood Group O Allels Boost Anti-A and Anti-B Titers in Blood Group O Recipients?

Human Papillomavirus 16

What do you do, with an M protein?

Right and wrong in antinuclear antibody tests. Timo Walle HUSLAB, Department of Immunology

Quant One Step RT-PCR Kit

Data Quality Worth Sharing

1 : TECHNICAL BASICS P SS. Axial distance, z

M. tuberculosis_mpb64/is611. genesig Advanced Kit. 150 tests. Primerdesign Ltd. For general laboratory and research use only

401 N. Washington Street, Suite 700, Rockville, MD Phone: Fax:

Transcription:

Antigen receptor (immunoglobulin and T-cell receptor) gene rearrangements: Utility in Routine Diagnostic Hematopathology DIAGNÓSTICO PRÁTICO DOS LINFOMAS São Paulo, Brasil 02 DE SETEMBRO DE 2011 Adam Bagg University of Pennsylvania Philadelphia, USA

Irene sends her apologies

Molecular targets

Rearrangements - physiologic - pathologic Molecular targets

Rearrangements - physiologic - pathologic Molecular targets

Molecular targets Rearrangements - physiologic - pathologic creation of a novel chimeric gene upregulated/overexpression of a protooncogene A B A B C A B t(9;22) bcr-abl qualitative t(8;14) IgH + c-myc quantitative

Molecular targets Rearrangements - physiologic - pathologic homogeneity vs heterogeneity creation of a novel chimeric gene present vs absent upregulated/overexpression of a protooncogene A B A B C A B t(9;22) bcr-abl qualitative t(8;14) IgH + c-myc quantitative

Molecular targets Rearrangements - physiologic - pathologic homogeneity vs heterogeneity Mutations creation of a novel chimeric gene present vs absent upregulated/overexpression of a protooncogene A B A B C A B t(9;22) bcr-abl qualitative t(8;14) IgH + c-myc quantitative

Molecular targets Rearrangements - physiologic - pathologic homogeneity vs heterogeneity Mutations Additions creation of a novel chimeric gene present vs absent upregulated/overexpression of a protooncogene Losses - deletions - silencing A C B A A B B t(9;22) bcr-abl qualitative t(8;14) IgH + c-myc quantitative

Antigen receptor (Ig and TCR) gene rearrangements

Antigen receptors Antigen Immunoglobulin T-cell receptor B-cell T-cell

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 4 5 23 1 2 3 4 5 6 µδγαε

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 4 5 23 1 2 3 4 5 6 µδγαε 1. DJ rearrangement

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 5 6 µδγαε 1. DJ rearrangement

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 5 6 µδγαε 1. DJ rearrangement 1 2 3 4 5 45 1 2 3 5 6 µδγαε

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 5 6 µδγαε 1. DJ rearrangement 1 2 3 4 5 45 1 2 3 5 6 µδγαε 2. V-DJ rearrangement

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 5 6 µδγαε 1. DJ rearrangement 1 2 3 5 6 µδγαε 2. V-DJ rearrangement

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 5 6 µδγαε 1. DJ rearrangement 1 2 3 5 6 µδγαε 2. V-DJ rearrangement 1 2 3 5 6 µδγαε

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 5 6 µδγαε 1. DJ rearrangement 1 2 3 5 6 µδγαε 2. V-DJ rearrangement 1 2 3 5 6 µδγαε 3. High power view V H 2 N D H 3 N J H 5

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 5 6 µδγαε 1. DJ rearrangement 1 2 3 5 6 µδγαε 2. V-DJ rearrangement 1 2 3 5 6 µδγαε 3. High power view V H 2 N D H 3 N J H 5 L FR I CDR I FR II CDR II FR III CDR III FR IV CDRs, FRs

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 5 6 µδγαε 1. DJ rearrangement 1 2 3 5 6 µδγαε 2. V-DJ rearrangement 1 2 3 5 6 µδγαε 3. High power view V H 2 N D H 3 N J H 5 L FR I CDR I FR II CDR II FR III CDR III FR IV CDRs, FRs and primers

IgH gene rearrangement and PCR V H D H J H C H 1 2 3 4 5 45 1 2 3 5 6 µδγαε 1. DJ rearrangement 1 2 3 5 6 µδγαε 2. V-DJ rearrangement 1 2 3 5 6 µδγαε 3. High power view V H 2 N D H 3 N J H 5 L FR I CDR I FR II CDR II FR III CDR III FR IV CDRs, FRs and primers

IgH gene rearrangement and PCR gel-based PCR product detection Size Poly Mono Mono Mono Poly Neg

TCRγ gene rearrangement and PCR V γ J γ C γ J γ C γ 1 2 3 4 5 6 7 8 9 10 11 P1 P 1 1 P2 2 2 VJ rearrangement 1 2 3 4 5 6 P2 2 2 High power view V γ 6 N J γ P2 Multiplex PCR Vγ1-8 Vγ9 Vγ10 Vγ11 JγP1 JγP Jγ1 JγP2 Jγ2

TCRγ gene rearrangement and PCR Atypical T-cell lymphoproliferations

TCRγ gene rearrangement and PCR Atypical T-cell lymphoproliferations capillary electrophoresis-based PCR product detection

TCRγ gene rearrangement and PCR Atypical T-cell lymphoproliferations capillary electrophoresis-based PCR product detection reactive

TCRγ gene rearrangement and PCR Atypical T-cell lymphoproliferations capillary electrophoresis-based PCR product detection reactive neoplastic

Other methods for AR GR Detection heteroduplex analysis SSCP DGGE microchip melting curve multichannel electrophoresis ligase chain reaction IGH PCR: usually straight-forward TRG PCR: more of an issue Interpretation relative peak height relative peak ratio height ratio peak height ratio best-fit normal distribution algorithm

Better Basis to Behold B- (and T-) cell clones: BIOMED 2 5 IGH 3 VJ 2 DJ hierarchy of IG GR 100% IG-lambda+ 97 primers 14 tubes 418 reactions 8 IG 6 TCR 2 IGK 1 IGL 3 TRB 2 TRG 1 TRD 1 VJ 1 Kde 1 VJ 2 VJ 1 DJ TRB analysis - 38 primers - 325 reactions will be IGK+ but ~5-10% IG-kappa+ will be IGL+ IGK and IGL also subjected to SHM, but? less so Kde reaction not affected by SHM

Better Basis to Behold B- (and T-) cell clones: BIOMED 2 97 primers 14 tubes 418 reactions 8 IG 6 TCR 5 IGH 2 IGK 1 IGL 3 TRB 2 TRG 3 VJ 2 DJ 1 VJ 1 Kde 1 VJ 2 VJ 1 DJ Incomplete DJ rearrangements ~30% IGH DJ+ in B-cell neoplasms up to 60% IGH DJ+ in myeloma ~60% TRB DJ+ in T-cell neoplasms excellent targets: - VJ primers will miss - since not transcribed, no SHM! 1 TRD

Better Basis to Behold B- (and T-) cell clones: BIOMED 2 Biomed Cambridge Tissue Frozen Fixed* T-cell lymphomas 94%** 98% B-cell lymphomas 99% 96% Pre-GC B (MCL) GC B (FL) 100% 84% 100% 30%*** * >300bp DNA product, excluded 21% cases ** 99% if exclude ALCL *** 13% with FR3 only [addition of IGK 100%] FR1 and FR2 better than FR3 in frozen

BIOMED 2 IG proposed algorithms Biomed 2 Frozen Cambridge Fixed 3 IGH VJ 1 st 98% 2 IGK 1 IGH VJ (FR2) 1 st 91% 2 IGK 2 IGH DJ 2 nd 99% 1 IGL 2 IGH VJ (FR1 & FR3) 2 nd 96% 1 IGL

Antigen receptor gene rearrangements Useful in the following situations:

Antigen receptor gene rearrangements Useful in the following situations: atypical lymphoproliferations

Antigen receptor gene rearrangements Useful in the following situations: atypical lymphoproliferations limited tissue

Antigen receptor gene rearrangements Useful in the following situations: atypical lymphoproliferations limited tissue equivocal immunophenotype

Antigen receptor gene rearrangements Useful in the following situations: atypical lymphoproliferations limited tissue equivocal immunophenotype T-cell lymphoproliferations

Antigen receptor gene rearrangements Useful in the following situations: atypical lymphoproliferations limited tissue equivocal immunophenotype T-cell lymphoproliferations baseline for MRD

Antigen receptor gene rearrangements Useful in the following situations: atypical lymphoproliferations limited tissue equivocal immunophenotype T-cell lymphoproliferations baseline for MRD BM: precursor B-cells

Antigen receptor gene rearrangements Useful in the following situations: atypical lymphoproliferations limited tissue equivocal immunophenotype T-cell lymphoproliferations baseline for MRD BM: precursor B-cells But not that helpful in:

Antigen receptor gene rearrangements Useful in the following situations: atypical lymphoproliferations limited tissue equivocal immunophenotype T-cell lymphoproliferations baseline for MRD BM: precursor B-cells But not that helpful in: diagnosing specific entities

Antigen receptor gene rearrangements Useful in the following situations: atypical lymphoproliferations limited tissue equivocal immunophenotype T-cell lymphoproliferations baseline for MRD BM: precursor B-cells But not that helpful in: diagnosing specific entities unraveling the heterogeneity

Pitfalls and caveats: Ig and TCR PCR False positives

Pitfalls and caveats: Ig and TCR PCR False positives - contamination

Pitfalls and caveats: Ig and TCR PCR False positives - contamination - pseudoclonality (small biopsies)

Pitfalls and caveats: Ig and TCR PCR False positives - contamination - pseudoclonality (small biopsies) - reactive/inflammatory scenarios H. pylori gastritis (but ) Hepatitis C (but ) Viral infections (HIV, mumps, EBV, CMV) Sjögren syndrome Rheumatoid arthritis

Pitfalls and caveats: Ig and TCR PCR False positives - contamination - pseudoclonality (small biopsies) - reactive/inflammatory scenarios H. pylori gastritis (but ) Hepatitis C (but ) Viral infections (HIV, mumps, EBV, CMV) Sjögren syndrome Rheumatoid arthritis - canonical (TCRγ)

Pitfalls and caveats: Ig and TCR PCR False positives - contamination - pseudoclonality (small biopsies) - reactive/inflammatory scenarios H. pylori gastritis (but ) Hepatitis C (but ) Viral infections (HIV, mumps, EBV, CMV) Sjögren syndrome Rheumatoid arthritis - canonical (TCRγ) - immune reconstitution post BMT - immune response to tumor

Pitfalls and caveats: Ig and TCR PCR False positives - contamination - pseudoclonality (small biopsies) - reactive/inflammatory scenarios H. pylori gastritis (but ) Hepatitis C (but ) Viral infections (HIV, mumps, EBV, CMV) Sjögren syndrome Rheumatoid arthritis - canonical (TCRγ) - immune reconstitution post BMT - immune response to tumor - clonal dermatitis

Pitfalls and caveats: Ig and TCR PCR False negatives

Pitfalls and caveats: Ig and TCR PCR False negatives - Preanalytic variables [degradation, fixation, representative sampling] - Technical consensus primers using CDR3 IgH primers only - Biologic pre GC/ precursor B-cells partial DJ oligoclonal (~1/3 precursor B-ALL) ongoing rearrangements at relapse intra/post GC somatic hypermutation (primary/ongoing) (follicular lymphoma, myeloma) IgH deletions (~1/10 lymphomas)

Pitfalls and caveats: Ig and TCR PCR False negatives - Preanalytic variables [degradation, fixation, representative sampling] - Technical consensus primers using CDR3 IgH primers only - Biologic pre GC/ precursor B-cells partial DJ oligoclonal (~1/3 precursor B-ALL) ongoing rearrangements at relapse intra/post GC somatic hypermutation (primary/ongoing) (follicular lymphoma, myeloma) IgH deletions (~1/10 lymphomas)

Pitfalls and caveats: Ig and TCR PCR False negatives - Preanalytic variables [degradation, fixation, representative sampling] - Technical consensus primers using CDR3 IgH primers only - Biologic pre GC/ precursor B-cells partial DJ oligoclonal (~1/3 precursor B-ALL) ongoing rearrangements at relapse intra/post GC somatic hypermutation (primary/ongoing) (follicular lymphoma, myeloma) IgH deletions (~1/10 lymphomas)

Pitfalls and caveats: Ig and TCR PCR False negatives - Preanalytic variables [degradation, fixation, representative sampling] - Technical consensus primers using CDR3 IgH primers only - Biologic pre GC/ precursor B-cells partial DJ oligoclonal (~1/3 precursor B-ALL) ongoing rearrangements at relapse intra/post GC somatic hypermutation (primary/ongoing) (follicular lymphoma, myeloma) IgH deletions (~1/10 lymphomas)

Pitfalls and caveats: Ig and TCR PCR False negatives - Preanalytic variables [degradation, fixation, representative sampling] - Technical consensus primers using CDR3 IgH primers only - Biologic pre GC/ precursor B-cells partial DJ oligoclonal (~1/3 precursor B-ALL) ongoing rearrangements at relapse intra/post GC somatic hypermutation (primary/ongoing) (follicular lymphoma, myeloma) IgH deletions (~1/10 lymphomas)

Pitfalls and caveats: Ig and TCR PCR False negatives - Preanalytic variables [degradation, fixation, representative sampling] - Technical consensus primers using CDR3 IgH primers only - Biologic pre GC/ precursor B-cells partial DJ oligoclonal (~1/3 precursor B-ALL) ongoing rearrangements at relapse intra/post GC somatic hypermutation (primary/ongoing) (follicular lymphoma, myeloma) IgH deletions (~1/10 lymphomas)

Any questions

ERROR: syntaxerror OFFENDING COMMAND: --nostringval-- STACK: /Title () /Subject (D:20110909104111-03 00 ) /ModDate () /Keywords (PDFCreator Version 0.9.5) /Creator (D:20110909104111-03 00 ) /CreationDate (Rosana) /Author -mark-